DFSVX | QRSAX | DFSVX / QRSAX | |
Total Expense Ratio | 0.31 | 0.90 | 34% |
Annual Report Gross Expense Ratio | 0.31 | 0.90 | 34% |
Fund Existence | 32 years | 4 years | - |
Gain YTD | -13.084 | -4.447 | 294% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.1B | 823M | 1,713% |
Annual Yield % from dividends | 1.65 | 0.84 | 197% |
Returns for 1 year | -3.65 | 3.52 | -104% |
Returns for 3 years | 6.50 | 14.56 | 45% |
Returns for 5 years | 90.41 | N/A | - |
Returns for 10 years | 24.22 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 47.46 | 1.35 | +2.93% |
ProShares Ultra Nasdaq Biotechnology | |||
USA | 6.37 | 0.05 | +0.79% |
Liberty All-Star Equity Fund | |||
BSMU | 21.33 | 0.05 | +0.21% |
Invesco BulletShares 2030 Muncpl Bd ETF | |||
DFP | 19.73 | 0.01 | +0.05% |
FLAHERTY & CRUMRINE DYNAMIC PREFERRED AND Income FUND | |||
RVRB | 26.79 | N/A | N/A |
Reverb ETF |